Internal Medicine • Research • Visualized

VISUALIZED: Trends in First Add-On Therapies to Metformin: Increasing Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Australia (2018–2020)

1 min read

Read further: Trends in First Add-On Therapies to Metformin: Increasing Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Australia (2018–2020)

About the author

Hippocrates Briefs Team